Showing results (391-400 of 476) with videos related to
Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Colorectal carcinoma in childhood and adolescence: a clinicopathologic reviewD Ashley Hill, Wayne L Furman, Catherine A Billups, et al.Cancer Treatment Reports|June 1, 1986
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adultsJ S Holcenberg, K D Tutsch, R H Earhart, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 25, 2019
Asymptomatic patients with unsuccessful percutaneous inferior vena cava filter retrieval rarely develop complications despite strut penetrations through the caval wallWande B Pratt, Harleen K Sandhu, Samuel S Leake, et al.Cancer|March 20, 2002
Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999Carlos Rodriguez-Galindo, Catherine A Billups, Larry E Kun, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.Journal of Medicinal Chemistry|August 28, 1999
Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anestheticS S Husain, S A Forman, M A Kloczewiak, et al.Cancer|June 20, 2001
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcomaW E Reddick, S Wang, X Xiong, et al.Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of topotecan for pediatric patients with malignant solid tumorsC B Pratt, C Stewart, V M Santana, et al.Pageof 48